Eli Lilly to invest $1.8bn in manufacturing capacity
Eli Lilly expands manufacturing facilities in Ireland with $1.8bn investment
With a new investment in its two manufacturing sites in Ireland, Eli Lilly continues implementing the largest expansion program in the company’s history.
Eli Lilly to invest over €1.6bn in Cork and Limerick sites as part of major expansion
As a part of this expansion, Lilly will create another 150 jobs for highly skilled workers in Limerick, bringing its total site workforce to 450.
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
Demand for Eli Lilly’s Zepbound and Mounjaro has outstripped supply over the last year, forcing the company to invest heavily to increase production.
Eli Lilly invests US$1bn in ongoing Irish expansion
AMERICAN pharmaceutical company Eli Lilly has invested US$1bn into the expansion of its manufacturing site in Limerick, Ireland, increasing the production of vital medicines for treating Alzheimer’s.
Eli Lilly invests $1.8 bln in Ireland sites to scale up Alzheimer's, obesity drug production
Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely popular obesity drug and a newly approved treatment for Alzheimer's, the drugmaker said on Thursday.
Eli Lilly Investing $1.8B to Expand its Manufacturing Facilities
This additional investment is part of the most ambitious manufacturing expansion agenda in the company's history. Since 2020, Lilly has committed more than $20 billion to build, expand and acquire manufacturing facilities in the U.S. and Europe.
Eli Lilly announces further $1bn investment in Limerick Alzheimer’s plant
Pharma giant Eli Lilly has announced a further $1 billion (€910 million) investment at the new Alzheimer’s medicines plant it is building in Limerick. The expansion of a plant that is still under construction will add a further 150 jobs to the 300 announced when the initial $1 billion investment in Limerick was announced in 2022.
Eli Lilly announces $1.8 billion manufacturing investment in Ireland
Nearly $1 billion will go toward expanding a facility that last year began making medicines for the company's new diabetes and obesity treatments.
Lilly expands manufacturing footprint in Ireland with $1.8 billion investment
Eli Lilly and Company (NYSE: LLY) today announced a $1 billion expansion of its Limerick, Ireland, manufacturing site to increase production of biologic active ingredients, including those for its recently approved treatment for early symptomatic Alzheimer's disease.
Lilly turns to Ireland to produce two of the hottest therapy areas in medicine
Company is investing $2.8bn in two Irish plants to produce its in-demand weight loss drugs and a new Alzheimer’s therapy ...
Cork Beo on MSN7d
Massive vote of confidence in Irish pharma as Eli Lilly unveils $800m Cork expansion
Eli Lilly has been in Cork for over 40 years and attributed its success to Ireland's skilled workforce and pro-innovation ...
NBC New York8d
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
Eli Lilly also announced a new $800 million facility expansion in Kinsale, Ireland, which started to make drugs last year to help meet demand for its diabetes and weight loss drugs. The ...
The Pharma Letter6d
Lilly’s Irish love affair goes on with $1.8 billion spend
Eli Lilly is investing $1 billion to expand its Limerick, Ireland site for biologic active ingredients, including Alzheimer's treatment components. This adds to a $2 billion total investment in ...